BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9919473)

  • 1. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
    Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
    Tamura T; Bergman SM; Morgan SL
    Int J Artif Organs; 1998 Feb; 21(2):72-4. PubMed ID: 9569127
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
    Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
    J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
    Weiss N; Pietrzik K; Keller C
    Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
    [No Abstract]   [Full Text] [Related]  

  • 7. Homocysteine and vascular disease.
    Wilcken DE
    Med J Aust; 1998 May; 168(9):431-2. PubMed ID: 9612453
    [No Abstract]   [Full Text] [Related]  

  • 8. B vitamins and homocysteine in cardiovascular disease and aging.
    Wilcken DE; Wilcken B
    Ann N Y Acad Sci; 1998 Nov; 854():361-70. PubMed ID: 9928444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The recommended daily intake of folic acid is insufficient for optimum homocysteine level].
    Willems HP; Den Heijer M; Gerrits WB; Bos GM
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1473-4. PubMed ID: 9752063
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperhomocysteinemia and the response to vitamin supplementation.
    Ubbink JB; van der Merwe A; Vermaak WJ; Delport R
    Clin Investig; 1993 Dec; 71(12):993-8. PubMed ID: 8124058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction.
    Leeda M; Riyazi N; de Vries JI; Jakobs C; van Geijn HP; Dekker GA
    Am J Obstet Gynecol; 1998 Jul; 179(1):135-9. PubMed ID: 9704778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homocysteine and cardiovascular risk].
    Lutteri L; Chapelle JP; Gielen J
    Rev Med Liege; 1999 Jun; 54(6):541-7. PubMed ID: 10446525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.
    Jardine MJ; Kang A; Zoungas S; Navaneethan SD; Ninomiya T; Nigwekar SU; Gallagher MP; Cass A; Strippoli G; Perkovic V
    BMJ; 2012 Jun; 344():e3533. PubMed ID: 22695899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
    de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
    J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
    Christen WG; Glynn RJ; Chew EY; Albert CM; Manson JE
    Arch Intern Med; 2009 Feb; 169(4):335-41. PubMed ID: 19237716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?
    Meleady R; Graham I
    Nutr Rev; 1999 Oct; 57(10):299-305. PubMed ID: 10575905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine levels and cardiovascular disease.
    Stampfer MJ
    Am Fam Physician; 1997 Oct; 56(6):1568, 1571-2. PubMed ID: 9351424
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperhomocysteinemia in organ transplantation.
    Sunder-Plassmann G; Floth A; Födinger M
    Curr Opin Urol; 2000 Mar; 10(2):87-94. PubMed ID: 10785848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vitamins B12, B6, and folate on blood homocysteine levels.
    Mason JB; Miller JW
    Ann N Y Acad Sci; 1992 Sep; 669():197-203; discussion 203-4. PubMed ID: 1444025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.